Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: Single-center experience of long-term follow-up and complications in 60 patients

Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: Single-center experience of long-term follow-up and complications in 60 patients

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a major cause of ventricular tachycardia (VT) and cardiac arrest in young patients. We hypothesized that treatment with implantable cardioverter/defibrillators (ICDs) is safe and improves the long-term prognosis of ARVC patients at high risk...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation (New York, N.Y.) N.Y.), 2004-03, Vol.109 (12), p.1503-1508
Hauptverfasser: WICHTER, Thomas, PAUL, Matthias, SCHELD, Hans H, BREITHARDT, Günter, BÖCKER, Dirk, WOLLMANN, Christian, ACIL, Tayfun, GERDES, Petra, ASHRAF, Obaidullah, TJAN, Tonny D. T, SOEPARWATA, Rasijd, BLOCK, Michael, BORGGREFE, Martin
Format: Artikel
Sprache:eng
Schlagworte:
Adolescent
Adult
Aged
Anti-Arrhythmia Agents - therapeutic use
Arrhythmogenic Right Ventricular Dysplasia - complications
Arrhythmogenic Right Ventricular Dysplasia - drug therapy
Arrhythmogenic Right Ventricular Dysplasia - therapy
Biological and medical sciences
Blood and lymphatic vessels
Cardiology. Vascular system
Combined Modality Therapy
Defibrillators, Implantable - adverse effects
Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
Electric Countershock
Electrocardiography
Equipment Failure
Female
Fibrosis
Humans
Intraoperative Care
Male
Medical sciences
Middle Aged
Proportional Hazards Models
Prospective Studies
Syndrome
Terminology as Topic
Treatment Outcome
Ventricular Fibrillation - etiology
Ventricular Fibrillation - prevention & control
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a major cause of ventricular tachycardia (VT) and cardiac arrest in young patients. We hypothesized that treatment with implantable cardioverter/defibrillators (ICDs) is safe and improves the long-term prognosis of ARVC patients at high risk of sudden death. Sixty patients with ARVC (aged 43+/-16 years) were treated with transvenous ICD systems. Despite a higher number of right ventricular sites tested for adequate lead positions (P
ISSN:0009-7322
1524-4539
DOI:10.1161/01.CIR.0000121738.88273.43